Skip to main content
Figure 6 | Cell Communication and Signaling

Figure 6

From: The scaffold protein MEK Partner 1 is required for the survival of estrogen receptor positive breast cancer cells

Figure 6

The PI3K/Akt pathway is required for survival of MCF-7 but not MDA-MB-231 cells. MCF-7 and MDA-MB-231 cells were treated with various concentrations of LY294002 for 48 h. (A) Immunoblot of p-Akt in MCF-7 and MDA-MB-231 cells treated with LY294002. (B) Effects of LY294002 treatment on viability as determined by trypan blue exclusion assays (n = 3). (C) Immunoblot of PARP cleavage in MCF-7 and MDA-MB-231 cells treated with LY294002.

Back to article page